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The present study investigated the real potential of a crude extract produced by T. pubescens MUT 2400 
with high laccases concentration, to degrade pharmaceuticals and recognized EDCs. The enzymatic 
treatment was applied toward a model solution and real municipal wastewater samples, containing some 
pharmaceutically active compounds. Laccases were able to extensively degrade all the tested compounds 
and an important detoxification of real wastewaters was also observed. 
1. Introduction  
Pharmaceuticals are part of the daily routine life, being used in human and animal medicine as 
therapeutics. After excretion as metabolites modified during Phase I and Phase II metabolism, more than 
4,000 pharmaceutically active compounds (PhACs) may even reach the aquatic system (Mompelat et al., 
2009). Landfill leachates, hospital and pharmaceutical effluents and, above all, municipal wastewaters 
result contaminated (Fatta-Kassinos et al., 2011).  
In the past decades, several PhACs (i.e. acetylsalicylic acid, ibuprofen, paracetamol, ketoprofen, 
naproxen, diclofenac, β-blockers) have been detected in river, lakes, and even drinking waters with the 
average concentration ranging between μg/L and ng/L (Christen et al., 2010; Vulliet et al., 2011).  
The knowledge about the fate of these contaminants in waters is barely known as well as their putative 
impact on aquatic organisms and human beings (Christen et al., 2010). One of the main concern is due to 
the fact that actually, some PhACs interfere with the endocrine system, mimicking natural hormones 
activity by selectively interact with estrogens receptors active site (Fent et al., 2006a). Hence, they have 
been classified as Endocrine Disrupting Chemicals (EDCs). In particular, an estrogenic activity has been 
already associated to estradiol derivates, genistein, paracetamol, antibiotics, etc. (Christen et al., 2010; 
Frye et al., 2011). They cause adverse effects on reproduction and fetal development, but they have been 
also associated to the rising of antibiotic resistance and allergies reactions (Christen et al., 2010).  
According to these results, PhACs, including EDCs, have to be degraded before their release in the 
environment. Wastewater treatment plants (WWTPs) are the first and the main barrier that have to face 
the presence of these pollutants. Unfortunately, the conventional methods are not design for this purpose 
and they result usually inefficient. As a consequence, PhCAs are released in the receiving bodies, 
contaminating surface and ground waters (Snyder et al., 2007). 
In order to solve this problematic, novel cost-effective and eco-friendly processes based on white-rot fungi 
are an attractive option (Cabana et al., 2007). Many strains have already recognized capable to degrade 
several xenobiotics, by means of their extracellular enzymatic pattern (Rodríguez Couto and Toca Herrera, 
2006). From an applicative point of view, the use of whole fungal cells poses serious drawbacks, both in 
terms of economical and operative sustainability. A promising alternative could be given by enzymatic 
treatments, which are eco-friendly and display low energy requirements and easy process control (Torres 
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et al., 2003). In particular, laccases are oxidoreductive enzymes with a low substrates specificity, which 
allow them to degrade many xenobiotics, including EDCs and pharmaceuticals (Cabana et al., 2007; Lloret 
et al., 2012). 
Considering available data, PhACs and EDCs are an actual issue of superficial waters in the Turin district 
(Schilirò et al., 2004). Hence, aim of this study was the development of a competitive treatment, active 
toward these pollutants: the crude extract of Trametes pubescens MUT 2400 with high laccases 
concentration was then used to treat model and real solutions, containing high amount of PhACs. 
2. Materials and Methods 
2.1 Chemicals 
All the chemicals, including several certified EDCs standards and pharmaceuticals, were purchased from 
Sigma-Aldrich (Milan, Italy): salicylic acid (99 %), naproxen (98 %), diclofenac (99 %), ketoprofen (99 %), 
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Figure 1: Chemical structures of the anti-inflammatory drugs salicylic acid, naproxen, diclofenac, 
ketoprofen) and hormones (estrone, 17-β-ethinyl estradiol) used in this study. 
2.2 Municipal wastewaters 
Water samples were collected from Turin municipal WWTP which treats around 42,000 m3/day and serves 
four towns of the metropolitan area and almost 250,000 inhabitants. The plant has several treatments 
including primary sedimentation, nitrification/denitrification, activated sludge oxidation, filtration, etc. Two 
municipal water samples were taken after the primary sedimentation (MW1 and MW2): they were 
representative of a 24 h cycle and were collected in different periods of the year (MW1 in April and MW2 in 
July 2012). Each sample (3 L) was stored in brown-glass flasks at 4 °C until experiments were run. 
2.3 Analytical analysis 
The analytical procedure combined Stir Bar Sorptive Extraction (SBSE) with in situ derivatization followed 
by Gas Chromatography and Mass Spectrometric Detection (GC-MS) (Bicchi et al., 2009). The analyses 
were carried out in the Department of Scienza e Tecnologia del Farmaco (University of Torino, Italy). 
The analytical method was validated according to international guidelines and by evaluating, its accuracy 
and the actual limit of quantification (LOQ) for each compounds. In particular, the accuracy was verified by 
analyzing water samples spiked with pure standards of suitable purity and stability at 10 µg/L. The 
accordance between the actual and the estimated concentration was compared in term of relative error 
percentage. The percentage of degradation (PD) of each pollutant was calculated by quantifying the 
residual concentration after the enzymatic treatment, in comparison with the data measured at the 
beginning of the experiment (untreated sample). Moreover, the half-life of the compounds (t1/2), was 
determined by extrapolation from the function that better fits with experimental values.  
2.4 Enzymatic treatment 
The culture filtrate of T. pubescens MUT 2400 was used at the final laccase concentration of 100 U/L. The 
experiment was carried out in 500 mL flask, using approximately 450 mL of each sample. The flasks were 
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maintained in a mild agitation (100 rpm) in order to keep a proper aeration. After 24 h, three aliquots of 10 
mL each were collected and immediately submitted to SBSE targeted sampling. The percentage of 
degradation (PD) and the half life (t1/2) of each pollutant were calculated by quantifying the residual 
concentration after the enzymatic treatment. 
Laccases were used towards a model solution and real municipal water samples. For the model solution, 
ultrapure water was spiked with 1 µg/L of selected compounds, indicated as potentially present in water 
courses by literature data and previous studies (Bicchi et al., 2009).  
During the entire experiment, in order to assess enzymes stability, the laccase activity was followed by 
means of a standardized method (Anastasi et al., 2012).  
2.5 Ecotoxicological analysis 
The ecotoxicity of real water samples was evaluated both before and after the enzymatic treatment. Since, 
little is known about the sensitivity of bioassays to the chemical complexity of superficial waters, in the 
present study, Lepidium sativum (plant) and Pseudokirchneriella subcapitata (alga) were selected because 
they have previously showed to be sensitive to contaminated industrial wastewaters (Anastasi et al., 
2012).  
3. Results and Discussion 
3.1 Laccases treatment of model solution 
To evaluate the potentials and the effectiveness of any treatment against xenobiotics, it is necessary to 
monitor the fate of the highest number of toxicants (Snyder et al., 2007) and, hence, a powerful and 
versatile validated procedure has to be used. Methodology performance parameters confirmed the fitness 
for purpose of the candidate method, and several figures of merit are reported in Table 1 as regard non 
steroidal anti-inflammatory drugs (salicylic acid, naproxen, diclofenac, ketoprofen) and hormones (estrone, 
17-β-ethinyl estradiol). Experimental data demonstrated that the method resulted to be highly sensitive to 
the presence of these compounds. With the only exception of ketoprofen, the Limit of Quantitation (LOQ) 
was always below 10 ng/L. This represents a key technical advantage, because the combination of GC-
MS allowed to surely identify and quantify several compounds, environmentally and toxicologically 
relevant, at very low concentration. In fact, many compounds have been recognized noxious for aquatic 
organisms, even at ng/L level. For example, hormones, as estrone or 17-β-ethynyl estradiol, are 
responsible of alterations in the normal reproduction system of fish and mudsnail already at 0.1 - 10 ng/L: 
they may cause sex differentiation, reduction of fertility or increase of eggs production (Christen et al., 
2010). 
The effectiveness of the laccase crude extract of T. pubescens MUT 2400 towards PhACs was first 
investigated on a model solution and the results are reported in Table 1. Salicylic acid, estrone and 17-β-
ethynyl estradiol were almost completely removed (PD > 90 %), lowering their concentration below 100 
ng/L. Naproxen and diclofenac were also extensively degraded, whereas ketoprofen was very recalcitrant 
(PD < 18 %) to the enzymatic oxidation. 
In general, laccase treatment was very rapid and, for most of the PhACs, their initial concentration halved 
within the first 24 h (Table 1). Interestingly, salicylic acid and hormones were degraded very rapidly, 
showing a t1/2 below 1 h. For the most recalcitrant compound (ketoprofen) the calculated t1/2 was higher 
than 5 days. 
Laccase activity remained stable at least for the first 8 h; at the end of the experiment, a minimal loss, 
around 10 %, was observed. The pH of the solution (7.3) did not have a destabilizing effect towards the 
enzymes, confirming that, in neutral solutions (pH 6 - 8), laccases result quite stable during time (Baldrian, 
2006). 
Table 1: Evaluation of parameters after the laccase treatment of the model solution. 
 LOQ laccases at 100 U/L
 PD residual conc t1/2 
salicylic acid 2.03 92.5 75 0.7 
naproxen 3.01 62.2 378 < 24.0 
diclofenac 1.51 56.0 440 32.0 
ketoprofen 12.5 17.5 825 144.0 
estrone 0.45 96.2 38 0.9 
17-β-ethinyl estradiol 8.74 91.5 85 0.1 
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LOQ: limit of quantification in ng/L of the pharmaceuticals used to spike the model solutions; PD: percentage of 
degradation; residual concentration in ng/L; t1/2: half life in hours of each compound after the laccases treatment of the 
model solution. 
3.2 Laccases treatment of municipal wastewaters 
Real water samples were collected in the Turin municipal WWTP in different periods of the year, in order 
also to get a first indication on the seasonal variability of the PhCAs present in the effluents.  
Working with complex and heterogeneous waters, the capability of the method to precisely quantify the 
presence of target compounds should be first evaluated. In fact, the heterogeneous chemical composition, 
suspended solid materials, etc. may eventually interfere with the analytical procedure. The results showed 
a good degree of accuracy, always below 20 % (data not shown). 
Thanks to this previous validation, it was possible to correctly estimate the concentration of several target 
PhACs in real wastewaters (Table 2). The chemical composition of the wastewaters differed both from a 
quantitative and qualitative point of view: MW1 showed a more various and consistent presence of PhACs 
in comparison with MW2. The main concern was ascribable to naproxen in MW1 and to ketoprofen in 
MW2, being present at quite high concentration (14 - 15 μg/L). Also for the other PhACs, the actual 
amount always exceeded the concentrations used to spiked the model solution. 
Even though hormones derivates were not detected in real municipal wastewaters, the hazard of these 
samples could be still considerable. In fact, some PhACs can bind the estrogen receptor as well as 
mediate other disturbing effects. For example, in rainbow trout, alterations of kidney and gills already 
happened at 5 μg/L (Fent et al., 2006a). Hence, as already pointed out by other authors, real samples 
confirmed to be highly contaminated (Christen et al., 2010). 
Knowing that the real water samples were actually contaminated, the enzymatic treatment was applied 
and the final yields are reported in Figure 2. Laccases of T. pubescens MUT 2400 were able to degrade all 
target compounds up to 70 %.  
It is important to underline that even though real samples were obviously more toxic and had a higher 
pollutants load than model solution, laccases still maintained their degradation capability. In fact, in a real 
water sample, many factors may inhibit or interfere with laccase activity, reducing the actual capability of 
the enzymes to mediate fruitful oxidation processes. In agreement with this assumption, a consistent 
inactivation of laccases was seen in both samples: after 24 h, only less than 40 % of the initial activity was 
left. Similar data were reported by other authors, highlighting the considerable destabilizing effect of 
reducing anions, organic solvents, heavy metals, cyanide, salts and suspended particles as well as 
phenolic secondary products of EDCs oxidation pathway (Cabana et al., 2007; Garcia et al., 2011).  
According to these evidences, the maintenance of the same process efficiency would have been already a 
good result. Interestingly, except for salicylic acid, the treatment of MWs highlighted a consistent 
enhancement of the PD values, in comparison with degradation yields obtained towards the model solution 
(Figure 2 and Table 1). A possible explanation of this unexpected result could be the presence, in the real 
water samples, of natural mediators, enhancing the enzymatic activity against pollutants (Cabana et al., 
2007; Garcia et al., 2011).  
After the enzymatic treatment, the residual concentration of the investigated compounds was comparable 
to the lowest concentration reported in the output effluents of the WWTPs (Figure 2), which ranges from 
few ng/L to even 12.5 μg/L for naproxen (Fent et al., 2006a). As already mentioned, the presence of small 
amounts of PhACs and EDCs should not mislead the attention, because toxic effects on the aquatic 
ecosystem have already been observed even at very low concentration of PhACs (Fent et al., 2006a).  
Table 2: Estimated concentration (μg/L) of the target compounds in the two municipal wastewater samples. 
nd = not detected.  
 estimated concentration
 MW1 MW2
salicylic acid 9.5 nd 
naproxen 15.3 2.2 
diclofenac 3.5 0.8 
ketoprofen 2.8 14.3 
estrone nd nd 
17-β-ethinyl estradiol nd nd 
total 31.1 17.3 









0 20 40 60 80 100








Figure 2: Percentage of degradation (PD) of the compounds detected in MW1 and MW2, after the 
enzymatic treatment. The final residual concentration (μg/L) of each compound is written closed to the bar.   
Moreover, as required by the European Medicines Evaluation Agency (EMEA), the ecotoxicological 
evaluation of PhACs compounds is necessary (Fent et al., 2006b). In the present study, both untreated 
samples were mildly toxic, inhibiting almost 20 % of the algal growth and of the seed germination index (IG 
%) (Figure 3). 
According to P. subcapitata test, the enzymatic treatment did not significantly change the hazard of the 
real samples: the modification of the chemical components mediated by laccases did not influence the 
algal development. Otherwise, considering the L. sativum test, laccase activity reduced the initial toxicity of 
MW1 and MW2. Actually, the enzymatic treatment even induced an important biostimulation of the seed 
germination, showing an IG > 100 % (Figure 3).  
Hence, the two model organisms did not respond in the same way to the MWs, confirming the need of a 
battery of ecotoxicological tests, able to give a complete picture of the potential hazard of a water sample 
(Tigini et al., 2011).  
 
 
Figure 3: Inhibition of the algal growth (I%) (left) and the seed index germination (IG %) (right) in presence 
of the untreated (before) and treated (after) MW1 and MW2.  
4. Conclusions 
The optimized analytical methodology applied in the present study, allowed to reliably identify and quantify 
many PhACs in real municipal water samples. Hence, PhACs are confirmed to be an actual issue in 
superficial waters, reaching even harmful levels. However, at least in Italy, the complete absence of any 
law regulation and restriction have not stimulated the development of suitable techniques, applicable in 
WWTPs and effective in degrading PhACs, including EDCs. 
Laccases of T. pubescens MUT 2400 highlighted a great potential to degrade several PhACs which can be 
found in municipal wastewaters. To date, for several compounds (i.e. salicylic acid, ketoprofen), this is the 
first time that an enzymatic treatment was successfully applied for their degradation, not only of model 
spiked solutions but also of real municipal wastewaters. Even though a consistent fraction of the enzymes 
was inactivated in real effluents, laccases were able to trigger efficient oxidative reactions cascade: the 
concentration of most of the molecules was reduced up to 70 % with a direct effect on samples ecotoxicity. 
In conclusion, despite the very promising results, the process has still to be optimized, improving its 
stability and efficiency. Several solutions are under investigation, including the immobilization of enzymes, 
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the addition of mediators and stabilizers and the selection of the most suitable location for the enzymatic 
treatment in WWTPs (Cabana et al., 2007). 
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